Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy

Thrombosis and Haemostasis

Volumn 87, Issue 5, 2002, Pages 808-811

  Ajzenberg, Nadine ^a   Denis, Cécile V ^a   Veyradier, Agnés ^a   Girma, Jean Pierre ^a   Meyer, Dominique ^a   Baruch, Dominique ^a  

^a INSERM   (France)

Author keywords

Metalloprotease; Platelet; Thrombotic thrombocytopenic purpura; Von Willebrand factor

Indexed keywords

GLYCOPROTEIN IB; GLYCOPROTEIN IB ANTIBODY GD1; METALLOPROTEINASE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME DEFICIENCY; HUMAN; MICROVASCULATURE; PATHOPHYSIOLOGY; PLASMA; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VON WILLEBRAND DISEASE;

EID: 0036251671     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613088     Document Type: Article

References (25)

1. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress
2. Pathophysiology and management of thrombotic microangiopathies
3. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
4. HUS and TTP: Variable expression of a single entity
5. Involvement of large plasma von Willebrand factor (vWf) multimers and unusually large vWf forms derived from endothelial cells in shear stress-induced platelet aggregation
6. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura
7. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
8. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
9. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family
10. Partial amino acid sequence of purified von Willebrand factor-cleaving protease
11. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura
12. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
13. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor
14. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: A study of 111 cases
15. Total deficiency of specific von Willebrand factor-cleaving protease and recovery following plasmatherapy in one patient with hemolytic uremic syndrome
16. Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF
17. Effect of recombinant von Willebrand factor reproducing type 2B or 2M mutations on shear-induced platelet aggregation
18. Platelet aggregation induced by a monoclonal antibody to the A1 domain of von Willebrand factor
19. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as platelet receptor for von Willebrand factor
20. Unusually large plasma factor VIII: Von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura
21. Thrombotic thrombocytopenic purpura: Understanding a disease no longer rare
22. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow
23. Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenia purpura
24. How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome
25. Antithrombotic effect of platelet glycoprotein Ib-blocking monoclonal antibody Fab fragments in nonhuman primates